Perez-Marreno R - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer.

Sartor O, Dineen MK, Perez-Marreno R, Chu FM, Carron GJ, Tyler RC. Sartor O, et al. Among authors: perez marreno r. Urology. 2003 Aug;62(2):319-23. doi: 10.1016/s0090-4295(03)00330-3. Urology. 2003. PMID: 12893343 Clinical Trial.

A six-month, open-label study assessing a new formulation of leuprolide 7.5 mg for suppression of testosterone in patients with prostate cancer.

Perez-Marreno R, Chu FM, Gleason D, Loizides E, Wachs B, Tyler RC. Perez-Marreno R, et al. Clin Ther. 2002 Nov;24(11):1902-14. doi: 10.1016/s0149-2918(02)80087-x. Clin Ther. 2002. PMID: 12501882 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters